All right, why don't we start off. I don't really want to talk about uh you know the individual moves, but we are seeing some short interest in these moves. Is this simply just a short squeeze or is there something else going on with these retail traders even maybe similar to what we saw in 2021.You know, in the in the retail world, there is a huge attraction to noise. So, what you're looking at right now is just a lot of noise and traders are always, you know, it's volatility's been dropping for the last m ...

Industry Overview - The U.S. cannabis industry is projected to reach approximately $39 billion in sales across medical and recreational markets in 2024, with analysts expecting consistent double-digit growth through the end of the decade [1] - Despite ongoing regulatory uncertainty, the sector continues to evolve as legalization gains ground and consumer demand grows [5] Penny Stocks Focus - Investors are currently focusing on marijuana penny stocks due to their explosive potential, which often react strongly to news, earnings, and market momentum [1] - Technical analysis is crucial for trading penny stocks, with traders monitoring volume surges, trendline breaks, and key support levels [2][4] Key Companies Planet 13 Holdings Inc. (PLNH) - Planet 13 is recognized for its Las Vegas SuperStore, which combines entertainment and retail, attracting both tourists and locals [6][10] - The company reported Q1 2025 revenue of approximately $25.7 million, with a gross profit of $11.6 million, resulting in a 45.1% gross margin [11] - Planet 13 operates nine dispensaries and is expanding in both recreational and medical markets, with expectations for revenue growth in the second half of 2025 [8][11] Cansortium Inc. (CNTMF) - Cansortium operates under the Fluent Cannabis Care brand and focuses on Florida's medical cannabis market, with 35 dispensaries in the state [12][14] - The company reported Q1 2025 revenue of $24.2 million, with a gross margin improvement to 57% [15] - Cansortium is positioned for future growth with plans to expand into Texas and Pennsylvania once regulations allow [14][15] Green Thumb Industries Inc. (GTBIF) - Green Thumb is one of the largest multi-state cannabis operators in the U.S., with over 100 dispensaries across 14 states [16][19] - The company posted Q1 2025 revenue of $280 million, reflecting a year-over-year increase of 1.5%, with a gross profit margin of 51.3% [20] - Green Thumb emphasizes cash preservation and long-term sustainability, maintaining a forecast for moderate growth in 2025 [20] Market Dynamics - Momentum in marijuana reform is a significant driver for the sector, with states expanding access despite the lack of federal legalization [3] - Technical setups combined with fundamental research can provide strong risk-reward scenarios for investors in the cannabis market [21]

The idea behind trading penny stocks is simple enough. Traders can buy a meaningful amount of shares without committing too much capital. If the stock moves just a few cents in their direction, they can generate significant profit. However, penny stocks carry significant risk. Most of these companies are small-cap or even micro-cap companies. Many are not profitable and may have little to no revenue. One way for penny stock traders to mitigate that risk is to look at stocks that analysts are behind. Some of ...

Group 1: Market Overview - After a volatile start to 2025 driven by trade tariff uncertainty, investors are seeking assets with strong upside potential, particularly in penny stocks, which are typically priced under $5 and offer a unique mix of risk and reward in uncertain markets [1][2] Group 2: Solid Power (NASDAQ: SLDP) - Solid Power is at the forefront of next-generation battery technology, developing solid-state batteries that promise higher energy density, faster charging, and improved safety compared to traditional lithium-ion batteries [3] - The company is backed by major automotive players Ford and BMW, has entered pilot production, and plans to conduct full-scale testing later in the year [3][4] - SLDP closed at $1.56, down 24% year to date, but has seen a more than 40% increase over the past month, indicating renewed investor interest [4] Group 3: Bitfarms (NASDAQ: BITF) - Bitfarms has gained attention due to the rebound in Bitcoin prices, operating primarily from hydro-powered facilities in Canada and Paraguay, and targeting over 21 exahashes per second by year-end [6][7] - The company could benefit from solid profit margins if Bitcoin prices remain stable, thanks to its energy-efficient operations, although it faces challenges such as capital intensity, price volatility, and regulatory scrutiny [7] - BITF stock is currently trading at $0.92, down 42% for the year, but has surged more than 35% since hitting a yearly low of $0.68 in April, showing signs of momentum [8]

Iovance's poor first quarter Penny stocks -- companies with shares trading at around $5 or even less apiece -- usually carry above-average risk. However, there may be hidden gems among them: companies with attractive prospects that continue to be ignored by most investors. Identifying those penny stocks with significant latent upside potential and investing in them before they catch fire can lead to life-changing returns. That brings us to Iovance Biotherapeutics (IOVA -5.03%), a small-cap biotech that has ...

Market Overview - The stock market is showing positive momentum as April closes, driven by hopes of easing trade tensions between China and the U.S. [1] - May presents a fresh opportunity for investors, particularly in penny stocks, as optimism around trade tariff resolutions builds [2][6] Company Analysis: Compass Therapeutics (NASDAQ: CMPX) - Compass Therapeutics has demonstrated strong stock performance in 2025, with a year-to-date increase of over 38%, currently trading at $1.94 [3][5] - The company is advancing its clinical pipeline, particularly with CTX-10726, a PD-1 x VEGF-A bispecific antibody, and plans to submit an IND by the end of 2025 [5][7] - Analysts predict a significant upside for CMPX, with a consensus "Buy" rating and an average price target of $12, indicating a potential increase of 527% over the next year [7] Company Analysis: Blade Air Mobility (NASDAQ: BLDE) - Blade Air Mobility operates a technology-enabled air transport platform, focusing on medical and passenger transportation, with expected double-digit growth in its medical business in 2025 [8] - The company has strengthened its financial position, achieving positive cash flow and maintaining a debt-free balance sheet with $136 million in cash, allowing for fleet growth and potential share buybacks [9] - Despite a recent rally of over 4% to $2.71, BLDE is down over 36% year-to-date, but analysts remain optimistic, forecasting a 117% upside with an average price target of $5.83 [9][11]

Market Overview - The S&P 500 ended March on a positive note despite a 6% decline in Q1, while the Nasdaq fell over 10% due to tariff uncertainty and profit-taking after a strong market recovery from 2022 lows [1] - Wall Street is currently struggling to find direction as it awaits updates on tariffs from Trump on April 2 [1] Earnings Outlook - The Nasdaq has dropped to neutral RSI levels, and the earnings growth outlook remains strong, with the Fed projected to cut interest rates twice in 2025 [2] Investment Opportunities - There is a focus on finding cheap stocks trading for $10 or less, with Wall Street analysts optimistic about their improving earnings outlooks [3] - Stocks priced under $10 are generally less risky than penny stocks, which are defined as stocks trading under $5 [4][6] Stock Screening Criteria - A screening process has been established for stocks under $10, including parameters such as an average broker rating of 3.5 or lower, a minimum trading volume of 1,000,000, and a Zacks Rank of 2 or better [8][9] - Rolls-Royce (RYCEY) is highlighted as a strong candidate, having increased over 650% in the past three years and currently trading at $10, which is 49% below its average Zacks price target of $14.60 [7][13] Rolls-Royce Performance - Rolls-Royce has seen a 55% increase in operating profit in 2024, with sales up by 16%, and is on track to quadruple profits by 2028 [10] - The company has reinstated its dividend and initiated a share buyback program, with projected revenue growth of 19% in 2025 and 8% in 2026, leading to adjusted earnings growth of 27% and 19%, respectively [11]

Market Overview - The stock market is experiencing a selloff as Wall Street shifts to a risk-off mode, influenced by the economic impact of the tariff battle [1] - The Nasdaq is approaching correction territory, primarily due to significant declines in Nvidia and other AI-related stocks, despite Nvidia's impressive long-term performance [1] Investor Sentiment - A contrarian buying signal, CNN's Fear & Greed Index, has dropped from a neutral level of around 50 in mid-February to an extreme fear level of 15, indicating a potential buying opportunity for long-term investors [2] - The Federal Reserve is projected to cut interest rates in 2025, with S&P 500 earnings per share (EPS) expected to grow by 13.2% in 2025 and 13.6% in 2026, compared to a projected growth of 7.4% in 2024 [2] Stock Selection Criteria - The article discusses strategies for identifying cheap stocks trading for $10 or less, suggesting that investors should consider buying during the current market weakness [3] - Stocks under $10 are categorized into penny stocks (under $5) and slightly less risky stocks (between $5 and $10), with the latter being more recognizable to investors [4][6] Stock Screening Parameters - A screening process is outlined for selecting stocks under $10, which includes criteria such as an average broker rating of 3.5 or lower, a minimum of two analysts covering the stock, and a Zacks Rank of 2 or better [7][8][9] BGC Group Analysis - BGC Group, Inc. is highlighted as a potential investment opportunity, with a projected revenue growth of 13% in 2023 and 12% in 2024, alongside a 21% increase in adjusted earnings for FY24 [10] - The company serves a diverse clientele and has reported trading volumes exceeding last year's first-quarter records [11] - BGC is expected to achieve an 8% revenue growth in 2025 and a 10% increase in sales in 2026, with adjusted earnings projected to grow by 17% in both years [12] - BGC stock has appreciated by 95% over the last five years, outperforming the Zacks Finance sector, and currently trades at a 50% discount to its sector with a dividend payout [12][13]